Group 1 - The core point of the article is that Boteng Co., Ltd. (SZ 300363) held a temporary board meeting on October 24, 2025, to review proposals including amendments to company-related systems [1] - For the first half of 2025, Boteng's revenue composition was as follows: small molecule API business accounted for 92.54%, emerging business accounted for 7.11%, and other businesses accounted for 0.36% [1] Group 2 - A notable event reported is a well-known brand's acquisition of 2,000 shares for 170 million yuan, despite the target company's registered capital being only 10,000 Hong Kong dollars and it not yet being operational [1] - The Shanghai Stock Exchange expressed confusion regarding the necessity of this acquisition given the significant premium involved [1]
博腾股份:10月24日召开董事会会议